The use of nanotechnology in medicine is known as nanomedicine. Drugs made with nanoparticles are a crucial feature of nanomedicine. These compounds provide a way to customize the biological distribution and pharmacokinetic analysis of active medicinal components. Given that the size and quality of nanoparticles directly influence how well they function in vivo, effective strategies for consistently generating high-quality nanoparticles with specified biophysical features are required. The local particle-formation context can be tightly controlled using microfluidic technologies in a continuous flow way. To increase volume productivity and manufacturing, process parameters optimized on single microfluidic mixer chips will be directly transferred to multi-mixer chips having identical channel geometry. Therefore, microfluidics creates a channel for the creation of high-quality nanoparticles that have been effectively transferred from the bench to the bedside.